Evidence map›Paper›PMID 42780472›Full record

ArticleFrontiers in immunology2026

Navigating coexisting autoimmunity and immunodeficiency in thymoma: a case report of TAMA, Good's syndrome, and myasthenic crisis.

Youwei Hao, Lizhen Wang, Ke Zheng, Renlong Zhao, Qi Wen, Jianli Wang, Wei Zhang, Juan Wang, Hongxia He, Ruifang Bai and 1 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Youwei Hao *Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Lizhen Wang *Department of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Ke ZhengDepartment of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Renlong ZhaoDepartment of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Qi WenDepartment of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Jianli WangDepartment of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Wei ZhangDepartment of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Juan WangDepartment of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Hongxia HeDepartment of Dermatology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Ruifang BaiDepartment of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Xueli ChangDepartment of Neurology, The First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coexistence of thymoma-associated multiorgan autoimmunity (TAMA) and Good's syndrome creates a challenging clinical scenario in which autoimmunity and profound immunodeficiency occur simultaneously. Here, we report a 37-year-old female with invasive WHO Type B3 thymoma and myasthenia gravis (MG) who developed progressive erythroderma-like skin lesions with graft-versus-host disease-like interface dermatitis. Immunological evaluation revealed marked hypogammaglobulinemia, absent circulating B cells, reduced CD4

Indexed as

Autoimmune DiseasesAutoimmunityImmunologic Deficiency SyndromesMyasthenia GravisThymomaThymus NeoplasmsAdultFatal OutcomeFemaleHumansGood syndromeimmune deficiencymyasthenia gravis (MG)thymomathymoma-associated multiorgan autoimmunity (TAMA)

Identifiers

PMID42780472
PMCPMC13597385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.